Literature DB >> 16537711

Variation in incidence and fatality of melanoma by season of diagnosis in new South Wales, Australia.

Mathieu Boniol1, Bruce K Armstrong, Jean-François Doré.   

Abstract

Seasonal variation in cutaneous melanoma incidence with a summer peak is poorly understood. It has been hypothesized to be due to increased diagnosis in summer or a late-promoting effect of sun exposure. We analyzed the characteristics of incident cases of cutaneous melanoma and their outcome by season of diagnosis in the population of New South Wales, Australia. Cases of melanoma (25,845 cases; 10,869 females and 14,976 males) were registered by the New South Wales Central Cancer Registry in 1989 to 1998. There was significant seasonal variation in incidence (P < 0.0001, Nam test). The summer to winter ratio was greater for women, younger people, lesions on the limbs, and superficial spreading melanoma. Melanomas were thicker in winter than in summer (medians 0.75 and 0.70 mm, respectively; P < 0.0001, Kruskal-Wallis test). Cases were followed for a median of 63 months and 2,710 (10.5%) died from their melanoma. Fatality from melanoma was lower for melanomas diagnosed in summer than winter (relative fatality = 0.72; 95% confidence interval, 0.65-0.81); the 5-year survival rate was 92.1% for diagnosis in summer and 89.0% for diagnosis in winter. This result remained significant after adjustment for year of diagnosis, age, sex, Breslow thickness, anatomic location, and histologic type (relative fatality = 0.82; 95% confidence interval, 0.72-0.94). Seasonality in melanoma incidence is probably caused mainly by increased and earlier diagnosis in summer, although a late-stage promotional effect of sun exposure cannot be excluded completely. Earlier diagnosis may also reduce fatality when melanoma is diagnosed in summer. Independence of variation in fatality with season from seasonal variation in thickness, however, suggests that sun exposure around the time of diagnosis decreases fatality of melanoma.

Entities:  

Mesh:

Year:  2006        PMID: 16537711     DOI: 10.1158/1055-9965.EPI-05-0684

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  13 in total

1.  Sun exposure and melanoma survival: a GEM study.

Authors:  Marianne Berwick; Anne S Reiner; Susan Paine; Bruce K Armstrong; Anne Kricker; Chris Goumas; Anne E Cust; Nancy E Thomas; Pamela A Groben; Lynn From; Klaus Busam; Irene Orlow; Loraine D Marrett; Richard P Gallagher; Stephen B Gruber; Hoda Anton-Culver; Stefano Rosso; Roberto Zanetti; Peter A Kanetsky; Terry Dwyer; Alison Venn; Julia Lee-Taylor; Colin B Begg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-28       Impact factor: 4.254

2.  Invited Commentary: Indoor Tanning-A Melanoma Accelerator?

Authors:  Marianne Berwick; Jean-François Doré
Journal:  Am J Epidemiol       Date:  2017-02-01       Impact factor: 4.897

Review 3.  Solar UV exposure and mortality from skin tumors.

Authors:  Marianne Berwick; Anne Lachiewicz; Claire Pestak; Nancy Thomas
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

4.  Melanocytic nevus development in Colorado children born in 1998: a longitudinal study.

Authors:  Lori A Crane; Stefan T Mokrohisky; Robert P Dellavalle; Nancy L Asdigian; Jenny Aalborg; Tim E Byers; Chan Zeng; Anna E Barón; Joanna M Burch; Joseph G Morelli
Journal:  Arch Dermatol       Date:  2009-02

5.  The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival.

Authors:  Irene Orlow; Yang Shi; Peter A Kanetsky; Nancy E Thomas; Li Luo; Sergio Corrales-Guerrero; Anne E Cust; Lidia Sacchetto; Roberto Zanetti; Stefano Rosso; Bruce K Armstrong; Terence Dwyer; Alison Venn; Richard P Gallagher; Stephen B Gruber; Loraine D Marrett; Hoda Anton-Culver; Klaus Busam; Colin B Begg; Marianne Berwick
Journal:  Pigment Cell Melanoma Res       Date:  2017-11-05       Impact factor: 4.693

Review 6.  Solar ultraviolet exposure and mortality from skin tumors.

Authors:  Marianne Berwick; Claire Pestak; Nancy Thomas
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

7.  Why vitamin D for cancer patients?

Authors:  S Gandini; Fp Francesco; H Johanson; B Bonanni; A Testori
Journal:  Ecancermedicalscience       Date:  2009-09-30

8.  Seasonal Variation in the Diagnosis of Skin Cancers From 1983 to 2017 in Greenville, North Carolina.

Authors:  Arthur M Samia; Joseph Nenow
Journal:  Cureus       Date:  2022-03-17

9.  Seasonal variation in diagnosis of invasive cutaneous melanoma in Eastern England and Scotland.

Authors:  Fiona M Walter; Gary A Abel; Georgios Lyratzopoulos; Jane Melia; David Greenberg; David H Brewster; Helen Butler; Pippa G Corrie; Christine Campbell
Journal:  Cancer Epidemiol       Date:  2015-07-02       Impact factor: 2.984

10.  Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).

Authors:  Robyn P M Saw; Bruce K Armstrong; Rebecca S Mason; Rachael L Morton; Kerwin F Shannon; Andrew J Spillane; Jonathan R Stretch; John F Thompson
Journal:  BMC Cancer       Date:  2014-10-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.